CurrentRheuma
Get Weekly

CurrentRheuma coverage · page 15 of 23

RMD Open

Briefs 561–600 of 899 CurrentRheuma has covered from this journal, newest publication first

Latest from RMD Open

All coverage, newest first

  1. RMD Open

    Risk of developing psoriatic arthritis in psoriasis cohorts with arthralgia: exploring the subclinical psoriatic arthritis stage

    Cohort studySpondyloarthritis & PsA

  2. RMD Open

    Incidence and outcome of COVID-19 following vaccine and hybrid immunity in patients on immunosuppressive therapy: identification of protective post-immunisation anti-RBD antibody levels in a prospective cohort study

    Cohort studyAcross diseases

  3. RMD Open

    Long-term clinical and radiological effectiveness and safety of ultralow doses of rituximab in rheumatoid arthritis: observational extension of the REDO trial

    Randomized controlled trialRA

  4. RMD Open

    Work-related physical strain and development of joint inflammation in the trajectory of emerging inflammatory and rheumatoid arthritis: a prospective cohort study

    Cohort studyRA

  5. RMD Open

    High prevalence of radiographic erosions in early, untreated PsA: results from the SpARRO cohort

    Cohort studySpondyloarthritis & PsA

  6. RMD Open

    Dynamic change in red cell distribution width as a predictor for short-time mortality in dermatomyositis-associated rapid progressive interstitial lung disease

    Cohort studyMyositis

  7. RMD Open

    Detection of hypophosphatasia in hospitalised adults in rheumatology and internal medicine departments: a multicentre study over 10 years

    Cohort studyAutoinflammatory & rare

  8. RMD Open

    Diagnostic accuracy in axial spondyloarthritis: a systematic evaluation of the role of clinical information in the interpretation of sacroiliac joint imaging

    Diagnostic or prognostic studySpondyloarthritis & PsA

  9. RMD Open

    Impact of DMARD treatment and systemic inflammation on all-cause mortality in patients with rheumatoid arthritis and interstitial lung disease: a cohort study from the German RABBIT register

    Cohort studyRA

  10. RMD Open

    Induction of regulatory T cells and efficacy of low-dose interleukin-2 in systemic sclerosis: interventional open-label phase 1–phase 2a study

    Research articleSystemic sclerosis

  11. RMD Open

    Obesity is a risk factor for poor response to treatment in early rheumatoid arthritis: a NORD-STAR study

    Secondary analysisRA

  12. RMD Open

    Recommendations for physical activity and exercise in persons living with Systemic Lupus Erythematosus (SLE): consensus by an international task force

    Guideline or statementLupus & APS

  13. RMD Open

    The HLA region in ANCA-associated vasculitis: characterisation of genetic associations in a Scandinavian patient population

    Case-control studyVasculitis & PMR

  14. RMD Open

    Guselkumab provides durable improvement across psoriatic arthritis disease domains: post hoc analysis of a phase 3, randomised, double-blind, placebo-controlled study

    Secondary analysisSpondyloarthritis & PsA

  15. RMD Open

    Incidence and clinical manifestations of giant cell arteritis in Spain: results of the ARTESER register

    Research articleVasculitis & PMR

  16. RMD Open

    DWI scrolling artery sign for the diagnosis of giant cell arteritis: a pattern recognition approach

    Diagnostic or prognostic studyVasculitis & PMR

  17. RMD Open

    Prediction of progressive fibrosing interstitial lung disease in patients with systemic sclerosis: insight from the CRDC cohort study

    Diagnostic or prognostic studySystemic sclerosis

  18. RMD Open

    Baricitinib for refractory Takayasu arteritis: a prospective cohort study in a tertiary referral centre

    Cohort studyVasculitis & PMR

  19. RMD Open

    Medication utilisation trends during pregnancy and factors influencing adverse pregnancy outcomes in patients with rheumatoid arthritis

    Cohort studyRA

  20. RMD Open

    Sex differences in cytokines and adipokines in obese patients with PsA and controls undergoing a weight loss intervention

    Secondary analysisSpondyloarthritis & PsA

  21. RMD Open

    Pain sensitisation and joint inflammation in patients with active rheumatoid arthritis

    Cross-sectional studyRA

  22. RMD Open

    Concordance and agreement between different activity scores in polymyalgia rheumatica

    Secondary analysisVasculitis & PMR

  23. RMD Open

    Long-term efficacy of a 2-year MRI treat-to-target strategy on disease activity and radiographic progression in patients with rheumatoid arthritis in clinical remission: 5-year follow-up of the IMAGINE-RA randomised trial

    Randomized controlled trialRA

  24. RMD Open

    Risk of serious infection associated with different classes of targeted therapies used in psoriatic arthritis: a nationwide cohort study from the French Health Insurance Database (SNDS)

    Cohort studySpondyloarthritis & PsA

  25. RMD Open

    Impact of filgotinib on pain control in the phase 3 FINCH studies

    Secondary analysisRA

  26. RMD Open

    Disease activity trajectories from childhood to adulthood in the population-based Nordic juvenile idiopathic arthritis cohort

    Cohort studyPediatric

  27. RMD Open

    The development and initial validation of IgG4-related disease damage index: a consensus report from Chinese IgG4-RD Consortium

    Guideline or statementAutoinflammatory & rare

  28. RMD Open

    Risk-stratified monitoring for sulfasalazine toxicity: prognostic model development and validation

    Cohort study

  29. RMD Open

    Hyperactivation and altered selection of B cells in patients with paediatric Sjogren’s syndrome

    Mechanistic studyPediatric

  30. RMD Open

    Persistence and safety of anti-TNF biosimilars versus originators in immune-mediated inflammatory diseases: an observational study on the French National Health Data System

    Cohort studyAcross diseases

  31. RMD Open

    Effectiveness and safety of adalimumab compared with leflunomide in patients with Takayasu arteritis: a retrospective cohort study

    Cohort studyVasculitis & PMR

  32. RMD Open

    Learning imaging in axial spondyloarthritis: more than just a matter of experience

    Diagnostic or prognostic studySpondyloarthritis & PsA

  33. RMD Open

    Remission definitions guiding immunosuppressive therapy in rheumatoid arthritis: which is best fitted for the purpose?

    Meta-analysisRA

  34. RMD Open

    Validity of an ultrasonographic joint-specific scoring system in juvenile idiopathic arthritis: a cross-sectional study comparing ultrasound findings of synovitis with whole-body magnetic resonance imaging and clinical assessment

    Cross-sectional studyPediatric

  35. RMD Open

    Impact of the time of initiation and line of biologic therapy on the retention rate of secukinumab in axial spondyloarthritis (axSpA): data from the French multicentre retrospective FORSYA study

    Cohort studySpondyloarthritis & PsA

  36. RMD Open

    Prospective study of complications and sequelae of glucocorticoid therapy in ANCA-associated vasculitis

    Cohort studyVasculitis & PMR

  37. RMD Open

    Characterisation of airway disease associated with Sjögren disease

    Cohort studySjögren's & overlap

  38. RMD Open

    Altered dynamic functional network connectivity in rheumatoid arthritis associated with peripheral inflammation and neuropsychiatric disorders

    Cross-sectional studyRA

  39. RMD Open

    Factors associated with satisfaction with social roles and activities among people with systemic sclerosis: a Scleroderma Patient-centered Intervention Network (SPIN) cohort cross-sectional study

    Cross-sectional studySystemic sclerosis

  40. RMD Open

    Long-term effectiveness of a lifestyle intervention for rheumatoid arthritis and osteoarthritis: 1-year follow-up of the ‘Plants for Joints’ randomised clinical trial

    Randomized controlled trialRA

All 899 Briefs in ExploreShowing Briefs 561–600 of 899, newest first